financetom
Business
financetom
/
Business
/
Softbank approves remaining $22.5 billion of OpenAI investment, The Information reports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Softbank approves remaining $22.5 billion of OpenAI investment, The Information reports
Oct 25, 2025 2:30 PM

(Reuters) -Softbank has approved a second installment of $22.5 billion to complete its $30 billion investment in OpenAI, the Information reported on Saturday.

The Japanese investment group's board has approved the installment as long as the artificial intelligence startup completes a corporate restructuring that would pave the way for an eventual public offering, the Information report said, citing a person with knowledge of the decision.

Reuters could not immediately verify the report.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Rhythm Names PANTHERx Rare as Exclusive US Pharmacy Partner for Imcivree's Expanded Indication
Rhythm Names PANTHERx Rare as Exclusive US Pharmacy Partner for Imcivree's Expanded Indication
Mar 20, 2026
01:43 PM EDT, 03/20/2026 (MT Newswires) -- Rhythm Pharmaceuticals ( RYTM ) has selected PANTHERx Rare as the exclusive US pharmacy distribution partner for the expanded indication of Imcivree, or setmelanotide, to treat acquired hypothalamic obesity in patients aged 4 years and older, PANTHERx Rare said Friday. Acquired hypothalamic obesity is a rare disease with weight gain caused by an...
Janus Living Shares Rise in NYSE Debut
Janus Living Shares Rise in NYSE Debut
Mar 20, 2026
01:43 PM EDT, 03/20/2026 (MT Newswires) -- Janus Living (JAN) shares rose in their trading debut Friday on the New York Stock Exchange. The shares were up more than 16% at $23.36 in afternoon trading. The senior housing real estate investment trust priced its upsized initial public offering of 42 million shares at $20.00 apiece. After the IPO, Healthpeak Properties...
ImmunityBio Wins Macau Approval for Anktiva in Bladder Cancer
ImmunityBio Wins Macau Approval for Anktiva in Bladder Cancer
Mar 20, 2026
01:33 PM EDT, 03/20/2026 (MT Newswires) -- ImmunityBio ( IBRX ) said Friday that the Pharmaceutical Administration Bureau of the Macau Special Administrative Region, China, approved Anktiva, or nogapendekin alfa inbakicept-pmln, marking the drug's first authorization in Asia. The drug is approved for use in combination with Bacillus Calmette-Guerin to treat adults with BCG-unresponsive non-muscle invasive bladder cancer, including carcinoma...
BRIEF-Banco Macro Says It Has Entered Into Share Purchase Agreement To Acquire Banco Sáenz S.A.
BRIEF-Banco Macro Says It Has Entered Into Share Purchase Agreement To Acquire Banco Sáenz S.A.
Mar 20, 2026
March 20 (Reuters) - Banco Macro SA: * BANCO MACRO S.A. ANNOUNCES THAT IT HAS ENTERED INTO A SHARE PURCHASE AGREEMENT TO ACQUIRE BANCO SÁENZ S.A. * BANCO MACRO SA - PURCHASE PRICE EQUALS SHAREHOLDERS' EQUITY PLUS US$2 MILLION, SUBJECT TO ADJUSTMENTS ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved